Quest Pharmatech Stock Today
| QPT Stock | CAD 0.04 0.01 33.33% |
Performance8 of 100
| Odds Of DistressLess than 29
|
Quest PharmaTech is selling for under 0.04 as of the 28th of November 2024; that is 33.33 percent increase since the beginning of the trading day. The stock's lowest day price was 0.04. Quest PharmaTech has about a 29 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Quest PharmaTech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Quest PharmaTech Inc., a biotechnology company, develops and commercializes antibody based immunotherapeutic products for cancer. The company also owns the Photodynamic therapy technology for oncology and dermatology applications and develops Mab AR 9.6 against truncated O-glycan on MUC16 for targeted cancer therapy applications. The company has 169.13 M outstanding shares of which 709 shares are at this time shorted by private and institutional investors with about 0.02 days to cover all short positions. More on Quest PharmaTech
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Quest Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Quest PharmaTech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Quest PharmaTech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Ragupathy Madiyalakan |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Quest PharmaTech (QPT) is traded on TSX Venture Exchange in Canada and employs 5 people. Quest PharmaTech is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.77 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Quest PharmaTech's market, we take the total number of its shares issued and multiply it by Quest PharmaTech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Quest PharmaTech classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 169.13 M outstanding shares of which 709 shares are at this time shorted by private and institutional investors with about 0.02 days to cover all short positions.
Quest PharmaTech has accumulated about 4.41 M in cash with (342.42 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03.
Check Quest PharmaTech Probability Of Bankruptcy
Ownership AllocationQuest PharmaTech owns a total of 169.13 Million outstanding shares. Quest PharmaTech holds 17.06 pct. of its outstanding shares held by insiders and 0.0 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Quest Ownership Details
Quest PharmaTech Risk Profiles
Although Quest PharmaTech's alpha and beta are two of the key measurements used to evaluate Quest PharmaTech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 9.62 | |||
| Semi Deviation | 10.24 | |||
| Standard Deviation | 16.89 | |||
| Variance | 285.29 |
Quest Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Quest PharmaTech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Additional Tools for Quest Stock Analysis
When running Quest PharmaTech's price analysis, check to measure Quest PharmaTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest PharmaTech is operating at the current time. Most of Quest PharmaTech's value examination focuses on studying past and present price action to predict the probability of Quest PharmaTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest PharmaTech's price. Additionally, you may evaluate how the addition of Quest PharmaTech to your portfolios can decrease your overall portfolio volatility.